Anavex confirms positive preclinical epilepsy data for ANAVEX 2-73

Anavex Life Sciences Corp. has confirmed positive preclinical data for its lead drug candidate ANAVEX 2-73 for the potential treatment of epilepsy, validating it also as a prospective platform...